DNA Capital
Venture capitalActively deployingSão Paulo · Pre-Seed–Late Stage · 15 people tracked
Also known as DNA Capital VC
Investment thesis
DNA Capital invests exclusively in healthcare and healthtech, backing exceptional founders and management teams across both early and late stages. The firm emphasizes building leading healthcare businesses that deliver high-quality, ethical and humane products and services. Beyond capital, it supports portfolio companies with experienced partners, investment professionals, operators and a network of advisors to accelerate growth. The team draws on deep experience investing in and operating healthcare businesses, and positions itself as a long-term partner that stands behind its companies through their evolution.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from the firm's website & public directoriesWhat they invest in
from 2 of 9 portfolio companiesDigital Health ×2EdTech ×1Healthtech ×1Mental Health ×1
HQs:Brazil×2
Investments · 9 tracked
founders shown can be your intro pathBeep is a fully digital home healthcare service that provides laboratory tests (5,000+ types), vaccines, and infusions at the patient's home, booked via its app or website.
Digital HealthHealthtech
Co-investorsThe Lightsmith GroupValor Capital Group
Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.
Zach Weinberg(Founder)in
Co-investorsAlleyCorpARCH Venture PartnersF-Prime CapitalGV (Google Ventures)Shine CapitalAlley Robotics Ventures+1 more
Frequently asked questions
- How many investments has DNA Capital made?
- DNA Capital has 9 tracked investments.
- What stage does DNA Capital invest at?
- DNA Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is DNA Capital's typical check size?
- DNA Capital typically writes checks of $100K – $5M.
- What sectors does DNA Capital focus on?
- DNA Capital focuses on Biotech, Digital Health, Healthtech.
- Where is DNA Capital located?
- DNA Capital is headquartered in São Paulo, BR.
- Does DNA Capital lead rounds?
- Yes, DNA Capital leads investment rounds.
- Who does DNA Capital co-invest with?
- DNA Capital most often shares deals with AlleyCorp, ARCH Venture Partners, F-Prime Capital, among 7 tracked co-investors.
Images
Co-investors · 6
Valor Capital Group is a cross-border venture fund connecting the US, Latin American, and global technology markets, investing in consumer internet and enterprise software companies.
High Alpha is a venture firm that creates and funds B2B SaaS companies, partnering with founders to build enterprise software businesses. It operates a venture capital arm (Capital) and a company-building arm (Studio).
HC9 Ventures is an early-stage venture firm investing in healthcare companies, leveraging the industry expertise of its limited partners and network to help startups refine product-market fit and scale.
Redpoint eventures is a venture capital firm supporting entrepreneurs by combining local and global VC benefits, including company building, financing, and exit support. It co-founded Cubo, a leading tech entrepreneurship hub in Latin America.
Matchstick Ventures is an early-stage venture capital firm that backs ambitious entrepreneurs located 'between the coasts,' investing capital, time, and resources at the pre-seed and seed stages.
Firms observed investing alongside DNA Capital, from public investor directories. Shared companies are the overlap with DNA Capital's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
Speedinvest operates a Portfolio Success program that connects its 400+ portfolio startups with customers, follow-on investors, industry experts, talent, discounted tools, and fellow founders across Europe, the Middle East, Africa, and beyond.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.
















.png)

